Search results for: 'medgen and acquisition deaco and alliance of 2004'
- Did you mean
- merger and acquisition deal and alliance of 2016
- Related search terms
- acquisition term and agreements in pharma
- acquisition test and agreements in pharma
- acquisitions terms and agreements in pharma
- medgen+and+acquisition+deal+and+alliance+of+2025
- medgen+and+acquisition+deal+and+alliances+of+2025
-
Distribution Deals in Medical Devices 2016-2026March 2026$3,995.00Distribution Deals in Medical Devices | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2026
Learn More -
Distribution Deals in Diagnostics 2016-2026March 2026$3,995.00Distribution Deals in Diagnostics | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2026
Learn More -
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019 to 2026March 2026$3,995.00Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2026
Learn More -
Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026March 2026$4,995.00The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report offers in-depth insights and exclusive access to clinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More -
Co-development Deals in Pharmaceuticals and Biotechnology 2016-2026March 2026$3,995.00Analyze co-development deals in pharma and biotech from 2016 to 2026. Includes financials, deal terms, and access to actual contracts where available.
Learn More -
Generic Pharmaceutical Partnering Terms and Agreements 2010-2026January 2026$3,995.00Global Generic Pharmaceutical Partnering Terms and Agreements 2010 to 2026 report provides a detailed understanding and analysis of how and why companies enter generic pharmaceutical partnering deals.
Learn More -
Royalty Rates in Pharmaceutical and Biotechnology Deals 2015 to 2026March 2026$4,995.00Essential Benchmark Data for Dealmakers | Global coverage | Updated to 2026 | 11+ years of royalty rates | Deal financials | Contract documents | Royalty rate trends
Learn More -
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Monoclonal Antibody Collaboration and Licensing Deals 2019-2025November 2025$3,995.00Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Viral Vector Collaboration and Licensing Deals 2016-2025November 2025$3,995.00Viral Vector Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More
- Category CP Reports Store Remove This Item
